Navigation Links
Action Fabricators Expands its Footprint in the Healthcare Industry With the Launch of Laminin Medical Products

GRAND RAPIDS, Mich., June 21 /PRNewswire/ -- Action Fabricators announced today it has expanded its medical division with the launch of Laminin Medical Products (, which will focus on the engineering, manufacturing and assembly/packaging of medical products under contract with the Medical Device industry.  Laminin, with the help of a Michigan Economic Development Corporation (MEDC) grant through their Economic Development Job Training (EDJT) Program, showcased its new business venture at the Medical Design and Manufacturing Show earlier this month in New York City.  

With the introduction of Laminin, Action Fabricators leveraged its more than two decades of experience in manufacturing adhesive-backed products for various industries and its seven years serving the medical industry to uniquely position the company as a leader in contract manufacturing and packaging for medical suppliers.

"With the strong support and relationships Action Fabricators already has in the manufacturing space, Laminin is uniquely poised to gain an early leadership position in the wound care and medical device markets," said Jon Rudolph, President of Action Fabricators.  "We see tremendous potential as we continue to grow our presence in the medical market and expect to bring new expertise and new job opportunities to the region.

"We have made a significant investment in product development, clean-room manufacturing space, and in serving the customized needs of medical suppliers, and believe Laminin will help us accelerate our growth."

Laminin is an FDA-registered company that offers a powerful blend of state-of-the-art technology and clean rooms, experience in materials conversion, and more than two decades of collaborative supplier relationships through its parent company, Action Fabricators.

The origin of the name Laminin comes from a protein by the same name found in most cells and organs, which serves the primary function of binding together vital membranes necessary for survival.  Action Fabricators incorporates this message within the framework of its business, working toward an uncompromising commitment to values and providing the highest level of integrity to its customers and suppliers.  

About Laminin Medical Products

Laminin Medical Products is a premier contract manufacturer and packager of medical devices and disposable medical products.  The Company serves leading medical companies and distributors and is a division of Action Fabricators.  Action Fabricators has been custom converting a wide array of adhesive-backed foams, plastics, tapes and other materials for the past 20 years.  In 2009, the company moved to its 70,000 square-foot facility in Grand Rapids, Mich., where it provides specialized medical manufacturing solutions for a global client base.  To learn more about Laminin Medical Products, visit  or call (616) 977-3575.  

SOURCE Action Fabricators
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
2. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
3. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
4. AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic
5. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
6. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
7. Study Linking Increased Risk of Death to Severe Psoriasis a Call to Action
8. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
9. ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI
10. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
11. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
Post Your Comments:
(Date:11/30/2015)... 2015 North America was ... grow at a CAGR of 7.6% from 2015 to 2020. ... 135.6 million in 2014, and is expected to grow at a ... to the new Market Research Report "North America Cardiac Output Monitoring ... (Hospitals, ambulatory care, others) - Analysis And Forecast To 2020", the ...
(Date:11/30/2015)... --> --> ... by Product (Soft Tissue, All Tissue, Dental Welding Lasers), Application ... Geography - Global Forecast to 2020", published by MarketsandMarkets, is ... CAGR of 5.2% during the forecast period from 2015 to ... 62 Figures spread through 167 P ages and in-depth ...
(Date:11/30/2015)... MOUNTLAKE TERRACE, Wash. and ST. ... Cross and Express Scripts (NASDAQ: ESRX ) today ... benefit agreement. The partnership, which began in 1999, will ... --> --> After evaluating pharmacy ... process, Premera concluded that Express Scripts continues to offer ...
Breaking Medicine Technology:
(Date:11/30/2015)... , ... December 01, 2015 , ... ... Dale Jones as a 2015-2016 inductee into its VIP Woman of the ... NAPW is the nation’s leading networking organization exclusively for professional women, boasting 850,000 ...
(Date:11/30/2015)... ... December 01, 2015 , ... Live Very Well is ... insurance plans on . The multi-carrier insurance exchange platform offers individual ... allowing consumers to compare, quote and match plans to meet their needs. ...
(Date:11/30/2015)... ... 30, 2015 , ... Until now, the St. Louis Fetal Care Institute ... of Myelomeningocele Study) trial. One of these exclusion criteria was a BMI above 34.9. ... to 24.9 is considered normal, 25 - 29.9 is overweight and above 30 is ...
(Date:11/30/2015)... , ... November 30, 2015 , ... Stress, anxiety, illness, ... a parent worry about possible tumors? , Heather Spader, MD, a new pediatric neurosurgeon ... are common, some signs might point to tumors. , “Bad headaches that ...
(Date:11/30/2015)... ... November 30, 2015 , ... Thermi™, a world leader in ... its ThermiRFR temperature controlled radiofrequency platform has received CE marking and may now ... uses temperature as a clinical endpoint. The technology has been available in ...
Breaking Medicine News(10 mins):